CN102451461A - Traditional Chinese medicine (TCM) for treating hyperosteogeny - Google Patents

Traditional Chinese medicine (TCM) for treating hyperosteogeny Download PDF

Info

Publication number
CN102451461A
CN102451461A CN2010105370721A CN201010537072A CN102451461A CN 102451461 A CN102451461 A CN 102451461A CN 2010105370721 A CN2010105370721 A CN 2010105370721A CN 201010537072 A CN201010537072 A CN 201010537072A CN 102451461 A CN102451461 A CN 102451461A
Authority
CN
China
Prior art keywords
parts
tcm
chinese medicine
treating hyperosteogeny
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010105370721A
Other languages
Chinese (zh)
Inventor
贺琴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010105370721A priority Critical patent/CN102451461A/en
Publication of CN102451461A publication Critical patent/CN102451461A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a traditional Chinese medicine (TCM) for treating hyperosteogeny. The TCM is characterized in that the TCM is prepared from the following components in parts by weight: 100 parts of moxa salt, 50-60 parts of moxa sticks, 20-30 parts of radix paeoniae alba, 50-60 parts of herba lysimachiae, 30-40 parts of radix puerariae, 20-30 parts of rhizoma cibotii, 20-30 parts of aromatherapy essential oil and the balance of centipede and dry ginger. The TCM has the advantages of good effect on treating hyperosteogeny, low cost and no toxic or side effect.

Description

A kind of Chinese medicine of treating hyperosteogeny
Technical field
The present invention relates to the field of Chinese medicines.Relate in particular to a kind of Chinese medicine of treating hyperosteogeny.
Background technology
The medicine of present known treatment hyperosteogeny is many, but the treatment effect that has is good inadequately, and the cost that has is high.
Summary of the invention
The object of the invention is exactly many to the medicine of present known treatment hyperosteogeny, but the treatment effect that has is good inadequately, the deficiency of the cost height that has, and a kind of smelting treatment hyperosteogeny that provides is effective, the Chinese medicine that cost is low.
A kind of Chinese medicine of treating hyperosteogeny is characterized in that it is made up of AIYAN, Herba Lysimachiae, aromatic essential oil, Scolopendra, moxa roll and dried Rhizoma Zingiberis Recens, and its weight portion proportioning is:
AIYAN 100 moxa roll 50-60 Radix Paeoniae Alba 20-30
Herba Lysimachiae 50-60 Radix Puerariae 30-40 Rhizoma Cibotii 20-30
Aromatic essential oil 20-30.
Advantage of the present invention is: it is effective that it treats hyperosteogeny to smelting, and cost is low, has no side effect.
The specific embodiment
Get AIYAN 100g, moxa roll 50g, Radix Paeoniae Alba 20g, Herba Lysimachiae 50g, Radix Puerariae 30g, Rhizoma Cibotii 20g and be ground into powder, add aromatic essential oil 20g and mix well and get final product.This medicinal cloth collation package is processed warm moxibustion bag, during use warm moxibustion bag is heated to 50-60 ℃ of taking-up, the warm moxibustion bag after the heating was directly spread on affected part 20-30 minute, get final product.

Claims (1)

1. Chinese medicine of treating hyperosteogeny is characterized in that it is made up of AIYAN, Herba Lysimachiae, aromatic essential oil, Scolopendra, moxa roll and dried Rhizoma Zingiberis Recens, and its weight portion proportioning is:
AIYAN 100 moxa roll 50-60 Radix Paeoniae Alba 20-30
Herba Lysimachiae 50-60 Radix Puerariae 30-40 Rhizoma Cibotii 20-30
Aromatic essential oil 20-30.
CN2010105370721A 2010-10-27 2010-10-27 Traditional Chinese medicine (TCM) for treating hyperosteogeny Pending CN102451461A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105370721A CN102451461A (en) 2010-10-27 2010-10-27 Traditional Chinese medicine (TCM) for treating hyperosteogeny

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105370721A CN102451461A (en) 2010-10-27 2010-10-27 Traditional Chinese medicine (TCM) for treating hyperosteogeny

Publications (1)

Publication Number Publication Date
CN102451461A true CN102451461A (en) 2012-05-16

Family

ID=46035404

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105370721A Pending CN102451461A (en) 2010-10-27 2010-10-27 Traditional Chinese medicine (TCM) for treating hyperosteogeny

Country Status (1)

Country Link
CN (1) CN102451461A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104147580A (en) * 2014-08-29 2014-11-19 桂林市艾康科技有限公司 Moxa for treating hyperostosis

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104147580A (en) * 2014-08-29 2014-11-19 桂林市艾康科技有限公司 Moxa for treating hyperostosis
CN104147580B (en) * 2014-08-29 2017-10-24 桂林市艾康科技有限公司 A kind of moxa stick for treating osteoproliferation

Similar Documents

Publication Publication Date Title
CN101337061A (en) Blood circulation promoting pain preventing plaster
CN104013688A (en) Traditional Chinese medicine fever cooling patch
CN103784930A (en) Foot soaking composition
CN102451461A (en) Traditional Chinese medicine (TCM) for treating hyperosteogeny
CN102451462A (en) Moxa salt traditional Chinese medicine (TCM) for treating hyperosteogeny
CN101757320A (en) Decoction medicine for treating acute suppurative otitis media
CN202179689U (en) Far-infrared temperature-sensing dysmenorrhea plaster
CN102038906A (en) Medicament for treating psoriasis
CN202982360U (en) Thermal-therapy medicine bag
CN103721198A (en) Traditional Chinese medicine pill for treating flooding
CN101926871A (en) Method for preparing medicament for treating cold asthma
CN101721496A (en) Beriberi liquid
CN104352621A (en) Sunstroke preventing and treating foot bath powder
CN103566017A (en) Preparation method of traditional Chinese medicine wine for eliminating dampness and warming meridian
CN103721200A (en) Traditional Chinese medicine pill for treating sterility
CN105031014A (en) Decoction for treating erythema multiforme
CN104138501A (en) Traditional Chinese medicine for treating parasitic orchitis
CN103720967A (en) Traditional Chinese medicine pill for treating headache
CN102935127A (en) Traditional Chinese medicine preparation for treating toothache
CN104623052A (en) Gynecological dysmenorrheal treating salt package and production method thereof
CN103263689A (en) Novel sanitary towel with completely leakage-proof herbal core sheet
CN101569644A (en) External medicine for treating sweaty feet and beriberi
CN102600347A (en) Medical composition for softening hardness, dissipating stagnation and removing goitre
CN103721209A (en) Traditional Chinese medicine prescription for treating leukorrhea diseases caused by exuberance of interior dampness-heat
CN103565856A (en) Purslane pill

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120516